Lema, Matiyos
Cheme, Melese Chego
Shama, Adisu Tafari
Terefa, Dufera Rikitu
Geta, Edosa Tesfaye
Desalegn, Zelalem
Article History
Received: 1 March 2023
Accepted: 4 July 2024
First Online: 12 July 2024
Declarations
:
: The study was conducted under the declaration of Helsinki. The study was approved by the Wallaga University Institutional Review Board. Oral informed consent was given by parents or guardians to do clinical eye examinations for selected children. During our examination of the children with active trachoma, TEO 1% was indeed administered following the treatment protocol. This ointment, which is commonly used for the treatment of active trachoma, was provided to those children who were diagnosed with active trachoma during our study.
: Not applicable for this study.
: The authors declare no competing interests.